Arif Anwar

Dr. Arif Anwar, co-founder and former Sengenics CEO, has a prodigious track record spanning more than 20 years of success in commercializing cutting-edge life science technologies. He has held progressively senior positions in genomics, bioinformatics, and proteomics companies in the U.S., the UK and Singapore. His previous roles have included Co-Founder and Commercial Director of PhenoCure UK Ltd., Regional Director at DoubleTwist Inc. and Regional Manager at Clontech. He earned a PhD in biochemistry and a BSc in genetics from University College London.